Cargando…

Lipoxin A(4) Attenuates Cell Invasion by Inhibiting ROS/ERK/MMP Pathway in Pancreatic Cancer

Lipoxin A(4) (LXA(4)), an endogenous arachidonic acid metabolite, was previously considered an anti-inflammatory lipid mediator. But it also has the potential to inhibit cancer progression. To explore the therapeutic effect of LXA(4) in pancreatic cancer, we used Panc-1 cells to investigate the mech...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zong, Liang, Li, Jiahui, Chen, Xin, Chen, Ke, Li, Wei, Li, Xuqi, Zhang, Lun, Duan, Wanxing, Lei, Jianjun, Xu, Qinhong, Shan, Tao, Ma, Qingyong, Sun, Hao
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4663743/ https://www.ncbi.nlm.nih.gov/pubmed/26649143 http://dx.doi.org/10.1155/2016/6815727

Ejemplares similares

Lipoxin A4 reverses mesenchymal phenotypes to attenuate invasion and metastasis via the inhibition of autocrine TGF-β1 signaling in pancreatic cancer
por: Zong, Liang, et al.
Publicado: (2017)

Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK
por: HUANG, XIN, et al.
Publicado: (2015)

Chronic alcohol exposure exacerbates inflammation and triggers pancreatic acinar-to-ductal metaplasia through PI3K/Akt/IKK
por: Huang, Xin, et al.
Publicado: (2023)

The Relevance of Nrf2 Pathway and Autophagy in Pancreatic Cancer Cells upon Stimulation of Reactive Oxygen Species
por: Zhang, Lun, et al.
Publicado: (2016)

Hydrogen peroxide mediates hyperglycemia-induced invasive activity via ERK and p38 MAPK in human pancreatic cancer
por: Li, Wei, et al.
Publicado: (2015)

Disrupting the Balance between Tumor Epithelia and Stroma is a Possible Therapeutic Approach for Pancreatic Cancer
por: Wang, Zheng, et al.
Publicado: (2014)

Inhibiting YAP expression suppresses pancreatic cancer progression by disrupting tumor-stromal interactions
por: Jiang, Zhengdong, et al.
Publicado: (2018)

Pancreatic carcinoma-specific immunotherapy using novel tumor specific cytotoxic T cells
por: Lei, Jianjun, et al.
Publicado: (2016)

Resveratrol Ameliorates the Malignant Progression of Pancreatic Cancer by Inhibiting Hypoxia-induced Pancreatic Stellate Cell Activation
por: Xiao, Ying, et al.
Publicado: (2020)

miR-221/222 induces pancreatic cancer progression through the regulation of matrix metalloproteinases
por: Xu, Qinhong, et al.
Publicado: (2015)

Pancreatic stellate cells contribute pancreatic cancer pain via activation of sHH signaling pathway
por: Han, Liang, et al.
Publicado: (2016)

Hedgehog signaling regulates hypoxia induced epithelial to mesenchymal transition and invasion in pancreatic cancer cells via a ligand-independent manner
por: Lei, Jianjun, et al.
Publicado: (2013)

α-Mangostin Suppresses the Viability and Epithelial-Mesenchymal Transition of Pancreatic Cancer Cells by Downregulating the PI3K/Akt Pathway
por: Xu, Qinhong, et al.
Publicado: (2014)

Stromal-derived factor-1α/CXCL12-CXCR4 chemotactic pathway promotes perineural invasion in pancreatic cancer
por: Xu, Qinhong, et al.
Publicado: (2014)

Ginkgolic acid suppresses the development of pancreatic cancer by inhibiting pathways driving lipogenesis
por: Ma, Jiguang, et al.
Publicado: (2015)

Reactive Oxygen Species and Targeted Therapy for Pancreatic Cancer
por: Zhang, Lun, et al.
Publicado: (2016)

Overexpression of Nodal induces a metastatic phenotype in pancreatic cancer cells via the Smad2/3 pathway
por: Duan, Wanxing, et al.
Publicado: (2015)

β(2)-Adrenogenic signaling regulates NNK-induced pancreatic cancer progression via upregulation of HIF-1α
por: Zhang, Dong, et al.
Publicado: (2015)

Curcumin Suppresses Hepatic Stellate Cell-Induced Hepatocarcinoma Angiogenesis and Invasion through Downregulating CTGF
por: Shao, Shan, et al.
Publicado: (2019)

Hyperglycemia, a Neglected Factor during Cancer Progression
por: Duan, Wanxing, et al.
Publicado: (2014)

Regional Arterial Infusion with Lipoxin A(4) Attenuates Experimental Severe Acute Pancreatitis
por: Yang, Fajing, et al.
Publicado: (2014)

High glucose microenvironment accelerates tumor growth via SREBP1-autophagy axis in pancreatic cancer
por: Zhou, Cancan, et al.
Publicado: (2019)

Lipoxin and Aspirin-Triggered Lipoxins
por: Romano, Mario
Publicado: (2010)

Positive feedback in Cav‐1‐ROS signalling in PSCs mediates metabolic coupling between PSCs and tumour cells
por: Shao, Shan, et al.
Publicado: (2020)

PTTG regulates the metabolic switch of ovarian cancer cells via the c-myc pathway
por: Wang, Xiu, et al.
Publicado: (2015)

Betulinic acid inhibits stemness and EMT of pancreatic cancer cells via activation of AMPK signaling
por: Sun, Liankang, et al.
Publicado: (2018)

Resveratrol Inhibits ROS-Promoted Activation and Glycolysis of Pancreatic Stellate Cells via Suppression of miR-21
por: Yan, Bin, et al.
Publicado: (2018)

NAF-1 Inhibition by Resveratrol Suppresses Cancer Stem Cell-Like Properties and the Invasion of Pancreatic Cancer
por: Qin, Tao, et al.
Publicado: (2020)

Lipoxin Receptors
por: Romano, Mario, et al.
Publicado: (2007)

Lipoxins and aspirin-triggered lipoxin inhibit inflammatory pain processing
por: Svensson, Camilla I., et al.
Publicado: (2007)

The EGFR-HSF1 axis accelerates the tumorigenesis of pancreatic cancer
por: Qian, Weikun, et al.
Publicado: (2021)

Cav-1 Ablation in Pancreatic Stellate Cells Promotes Pancreatic Cancer Growth through Nrf2-Induced shh Signaling
por: Shao, Shan, et al.
Publicado: (2020)

Resveratrol enhances the chemotherapeutic response and reverses the stemness induced by gemcitabine in pancreatic cancer cells via targeting SREBP1
por: Zhou, Cancan, et al.
Publicado: (2018)

Lipoxins and aspirin-triggered lipoxin alleviate bone cancer pain in association with suppressing expression of spinal proinflammatory cytokines
por: Hu, Shan, et al.
Publicado: (2012)

Lipoxins and Resolvins in Patients With Pancreatic Cancer: A Preliminary Report
por: Blogowski, Wojciech, et al.
Publicado: (2022)

Hypoxia‐driven paracrine osteopontin/integrin αvβ3 signaling promotes pancreatic cancer cell epithelial–mesenchymal transition and cancer stem cell‐like properties by modulating forkhead box protein M1
por: Cao, Junyu, et al.
Publicado: (2018)

Potent Antitumor Activity Generated by a Novel Tumor Specific Cytotoxic T Cell
por: Wang, Zheng, et al.
Publicado: (2013)

Editorial: The Microenvironment in Pancreatic Cancer and Therapeutic Strategies Targeting Microenvironment
por: Duan, Wanxing, et al.
Publicado: (2022)

Lipoxin A4 Preconditioning Attenuates Intestinal Ischemia Reperfusion Injury through Keap1/Nrf2 Pathway in a Lipoxin A4 Receptor Independent Manner
por: Han, Xue, et al.
Publicado: (2016)

Arl4c promotes the growth and drug resistance of pancreatic cancer by regulating tumor-stromal interactions
por: Chen, Xin, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_uhhdf508j8d5cba8ea875hqf2c